vida: extract claims from 2026-05-07-all-of-us-glp1-sud-75pct-lower-odds

- Source: inbox/queue/2026-05-07-all-of-us-glp1-sud-75pct-lower-odds.md
- Domain: health
- Claims: 0, Entities: 0
- Enrichments: 3
- Extracted by: pipeline ingest (OpenRouter anthropic/claude-sonnet-4.5)

Pentagon-Agent: Vida <PIPELINE>

domains/entertainment/ai-video-character-consistency-crossed-multi-shot-narrative-threshold-2026.md

@@ -0,0 +1,19 @@
+---
+type: claim
+domain: entertainment
+description: Subject Binding technology in Kling 3.0 maintains character identity across six-shot sequences within single generations, removing the technical barrier that prevented AI video from sustaining characters across narrative scenes
+confidence: experimental
+source: CineD coverage of Kling 3.0, February 2026
+created: 2026-05-08
+title: AI video character consistency crossed multi-shot narrative threshold in early 2026 enabling episodic production from synthetic starting points
+agent: clay
+sourced_from: entertainment/2026-05-03-cined-kling-30-multishot-narrative-capability.md
+scope: functional
+sourcer: CineD
+supports: ["character-consistency-unlocks-ai-narrative-filmmaking-by-removing-technical-barrier-to-multi-shot-storytelling", "GenAI-is-simultaneously-sustaining-and-disruptive-depending-on-whether-users-pursue-progressive-syntheticization-or-progressive-control", "non-ATL-production-costs-will-converge-with-the-cost-of-compute-as-AI-replaces-labor-across-the-production-chain"]
+related: ["character-consistency-unlocks-ai-narrative-filmmaking-by-removing-technical-barrier-to-multi-shot-storytelling", "ai-video-generation-crossed-episodic-production-threshold-2026-amazon-prime-deployment", "non-ATL-production-costs-will-converge-with-the-cost-of-compute-as-AI-replaces-labor-across-the-production-chain"]
+---
+
+# AI video character consistency crossed multi-shot narrative threshold in early 2026 enabling episodic production from synthetic starting points
+
+Kling 3.0's Subject Binding feature maintains character identity (clothing, accessories, facial features) across up to six distinct camera cuts within a single 15-second generation. This directly addresses what the source describes as 'THE remaining technical barrier preventing AI video from being used for narrative filmmaking' — the inability to sustain a character across a scene. Previous AI video models could produce beautiful individual shots but character drift made multi-shot sequences impossible without manual intervention. Combined with integrated audio and voice binding (which attaches specific voice profiles to characters and animates correct lip sync), creators can now generate complete multi-shot scenes with dialogue exchanges in a single generation pass. The 15-second generation length with six cuts means approximately 2.5 seconds per shot, which matches typical dialogue exchange pacing. At $0.05/second, a 7-minute animated episode costs approximately $21 in raw generation costs, making episodic production economically accessible. This represents a phase transition from 'AI video as individual shot tool' to 'AI video as narrative scene tool' — the building blocks of episodic content are now technically feasible.

domains/entertainment/ai-video-generation-crossed-episodic-production-threshold-2026-amazon-prime-deployment.md

@@ -31,3 +31,10 @@ Kling 3.0's multi-shot storyboarding (6 cuts per generation), Subject Binding fo
 # AI video generation crossed from experimental to planned episodic production workflow at major streamer scale in 2026
 
 House of David Season 2 (Amazon Prime, March 2026) integrated 253 AI-generated shots compared to 73 in Season 1 — a 3.5x increase in one production cycle. Critically, Season 2 had 'AI planned as workflow from start, not as a backup solution,' marking the transition from experimental to operational deployment. The production used Runway, Luma, Kling, and other tools alongside traditional VFX infrastructure (Unreal Engine, Nuke). Amazon MGM's Global Head of VFX Chris del Conte collaborated from January 2025, bringing AWS-powered virtual production infrastructure together with director Jon Erwin's vision. Over 100 shots were used specifically for virtual production LED panel environments. Director Jon Erwin's framing — 'If it's AI-detectable, you've failed' — suggests the production team believes they've passed the quality threshold for indistinguishability from traditional VFX. This is not indie experimentation but institutional integration: Amazon's VFX leadership planning AI into episodic workflow from pre-production. The 3.5x adoption velocity in a single year, combined with institutional planning rather than post-production rescue, indicates AI video generation has crossed the production viability threshold for major streaming content.
+
+
+## Extending Evidence
+
+**Source:** CineD, Kling 3.0 feature set, February 2026
+
+Kling 3.0's multi-shot storyboarding (six cuts per generation) with Subject Binding for character consistency provides the specific technical capability that enables episodic production. The 15-second generation length with integrated audio and voice binding means complete dialogue scenes are now possible in single generation passes.

domains/entertainment/character-consistency-unlocks-ai-narrative-filmmaking-by-removing-technical-barrier-to-multi-shot-storytelling.md

@@ -94,3 +94,10 @@ Kling 3.0 (April 2026) implements reference locking via uploaded material, enabl
 **Source:** VP-Land, House of David Season 2 production
 
 Kling deployed in Amazon Prime episodic production (House of David Season 2, 253 AI shots) alongside Runway, Luma, and other tools for character-dependent narrative content including battle scenes and horse close-ups. Director Jon Erwin presenting at Kling AI panel at Cannes May 18, 2026: 'From Creative Possibility to Production Reality.' Production-scale deployment validates character consistency has crossed professional threshold.
+
+
+## Supporting Evidence
+
+**Source:** CineD, Kling 3.0 Subject Binding, February 2026
+
+Kling 3.0's Subject Binding maintains character identity (clothing, accessories, facial features) across six-shot sequences within single generations, described by CineD as addressing 'THE remaining technical barrier' for narrative filmmaking. The Elements feature allows reference image uploads to define characters, providing consistent identity anchors.

domains/health/glp1-receptor-agonists-address-substance-use-disorders-through-mesolimbic-dopamine-modulation.md

@@ -189,3 +189,10 @@ Semaglutide + CBT for AUD achieved 41.1% reduction in heavy drinking days with N
 **Source:** NBC News/Pharmacy Times synthesis April 2026, Session 22 Science 2025 VTA dopamine circuit paper
 
 GLP-1 receptor agonists show evidence across multiple substance use disorders beyond AUD: (1) Opioid Use Disorder: liraglutide produced ~40% reduction in opioid craving in small RCT; semaglutide significantly reduced opioid overdose risk in 1-year follow-up for T2D+OUD patients (real-world data). (2) Nicotine: exenatide + NRT increased 7-day abstinence vs placebo at week 6, though long-term findings mixed; SEMALCO trial showed reduced cigarettes/day as secondary endpoint in AUD+smoking subgroup. (3) Cocaine/stimulants: liraglutide reduces operant methamphetamine intake in rats (preclinical only). Population-level evidence: among people with pre-existing SUD on GLP-1s, fewer ER visits, hospitalizations, and deaths across substance categories (observational data). As of April 2026: 33 clinical trials for SUD (15 AUD, 9 nicotine, 4 OUD, 4 cocaine). Evidence strength hierarchy: AUD > OUD > nicotine > cocaine.
+
+
+## Extending Evidence
+
+**Source:** Abegaz et al., Frontiers in Psychiatry 2026
+
+The All of Us study demonstrates GLP-1 effects extend across four distinct substance categories (alcohol, opioids, nicotine, cocaine) with similar effect sizes (OR 0.25-0.32), suggesting a shared reward circuit mechanism rather than substance-specific pharmacology. The cocaine use disorder effect size (OR=0.25, 75% reduction) is particularly notable as no behavioral intervention produces comparable CUD reduction, supporting a dopaminergic reward pathway as the common mechanism across all substance types.

domains/health/glp1-receptor-agonists-demonstrate-superior-efficacy-for-alcohol-use-disorder-in-comorbid-obesity-population.md

@@ -46,3 +46,10 @@ VigiBase pharmacovigilance analysis shows eating disorder signals with aROR 4.17
 **Source:** NBC News/Pharmacy Times April 2026
 
 Critical limitation applies across all SUD evidence: all human data comes from patients with comorbid metabolic disease (T2D or obesity). Whether GLP-1s work for SUD without metabolic comorbidity is unknown and largely unstudied. This constraint affects not just AUD but the entire SUD evidence base — OUD, nicotine, and cocaine trials all recruit from metabolically compromised populations.
+
+
+## Supporting Evidence
+
+**Source:** Abegaz et al., Frontiers in Psychiatry 2026
+
+All of Us AUD cohort (n=22,652) showed OR=0.26 for GLP-1 exposure after propensity score matching for diabetes/obesity status, confirming the AUD effect persists in metabolically diverse populations. This adds to the JAMA Psychiatry RCT evidence (41% heavy drinking reduction in obesity+AUD) and Swedish cohort data, forming a three-study convergence across observational, within-individual, and RCT designs.

domains/health/glp1-receptor-agonists-reduce-alcohol-use-disorder-risk-28-36-percent-across-5-26-million-patients.md

@@ -24,3 +24,10 @@ A systematic review and meta-analysis published in eClinicalMedicine synthesized
 **Source:** Osmind clinical article Q1 2026, citing 142K participant observational study
 
 Observational data from 142,000 participants showed 75% lower odds of developing ANY substance use disorder with GLP-1 exposure (not just AUD). Semaglutide showed 85% and 87% reductions in alcohol and opioid use disorder odds. This is broader than AUD alone and represents very large effect sizes in a non-clinical population. Osmind notes these 'effect sizes exceed those historically seen with naltrexone or acamprosate' from 2025 JAMA Psychiatry trial.
+
+
+## Extending Evidence
+
+**Source:** Abegaz et al., Frontiers in Psychiatry 2026
+
+All of Us nested case-control study (n=87,494 across four SUD subtypes) found GLP-1 exposure associated with OR=0.25 (95% CI 0.22-0.30) for any substance use disorder — 75% lower odds. This represents the largest observational effect size in the GLP-1 SUD literature. Specific subtypes: AUD OR=0.26 (74% reduction, n=22,652), OUD OR=0.31 (69% reduction, n=13,226), NUD OR=0.32 (68% reduction, n=42,320), CUD OR=0.25 (75% reduction, n=9,296). The convergence of three independent designs — this observational study (OR=0.25), Swedish within-individual cohort (47% SUD worsening reduction), and JAMA Psychiatry RCT (41% heavy drinking reduction, NNT 4.3) — with consistent direction despite different populations and methods strengthens causal inference beyond any single study.

inbox/archive/entertainment/2026-05-03-cined-kling-30-multishot-narrative-capability.md

@@ -7,10 +7,13 @@ date: 2026-02-01
 domain: entertainment
 secondary_domains: []
 format: article
-status: unprocessed
+status: processed
+processed_by: clay
+processed_date: 2026-05-08
 priority: high
 tags: [ai-video, production-costs, narrative-filmmaking, kling, character-consistency]
 intake_tier: research-task
+extraction_model: "anthropic/claude-sonnet-4.5"
 ---
 
 ## Content

inbox/archive/health/2026-05-07-all-of-us-glp1-sud-75pct-lower-odds.md

@@ -7,10 +7,13 @@ date: 2026-03-10
 domain: health
 secondary_domains: []
 format: article
-status: unprocessed
+status: processed
+processed_by: vida
+processed_date: 2026-05-08
 priority: high
 tags: [glp-1, substance-use-disorder, addiction, observational-study, all-of-us]
 intake_tier: research-task
+extraction_model: "anthropic/claude-sonnet-4.5"
 ---
 
 ## Content